Skip to main content
    I

    Immix Biopharma Inc (IMMX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.20
    -0.28 (-3.74%)

    Market Cap: $657.09M

    Last updated: Nov 17, 2026 at 4:33 PM ET

    Immix Biopharma Inc (IMMX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Immix Biopharma (IMMX) has a market cap of $657.09M and an enterprise value of $337.64M. Its share count is up 132.06% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 48.62% below the market cap, as cash exceeds debt.

    Market Cap$657.09M
    Enterprise Value$337.64M
    Latest price (Nov 17, 2026)$7.20

    Key Dates

    The next earnings report is expected on Mar 23, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 23, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 16.18% in the quarter ended Sep 30, 2026 and grew 58.68% a year over 2 years.

    Shares Outstanding74.09M
    Shares Change (YoY)+132.06%
    Shares Change (QoQ)+16.18%
    Share Count Growth (2Y CAGR)+58.68%

    Price Statistics

    The stock is up 71.02% over 52 weeks and trades 24.76% below its 50-day average.

    Beta (1Y)1.80
    52-Week Change+71.02%
    1-Month Change-12.41%
    3-Month Change-45.41%
    6-Month Change-18.74%
    Total Return (1Y)+71.02%
    Total Return (3Y CAGR)+18.19%
    Return vs SPY (1Y)+57.85%
    Max Drawdown (1Y)-50.24%
    Max Drawdown (3Y)-81.57%
    Sharpe Ratio (1Y)0.65
    Correlation with SPY (1Y)0.30
    50-Day Average$9.57
    200-Day Average$9.63
    52-Week Range$3.78 to $15.10
    RSI (14 Days)37.4
    Average Volume (20 Days)1.17M

    Price chart

    Financial Position

    Current assets cover 33.72x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio33.72x
    Quick Ratio33.72x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on invested capital is -14.91% over the last 12 months, against a 5-year average of -31.62%.

    Return on Equity (ROE)-13.81%
    Return on Assets (ROA)-13.37%
    Return on Invested Capital (ROIC)-14.91%
    ROE (5Y Average)-97.65%
    ROA (5Y Average)-78.03%
    ROIC (5Y Average)-31.62%

    Scores

    IMMX has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$90.63K
    Operating Income-$50.10M
    Pretax Income-$46.23M
    Net Income-$46.26M
    Reported EPS (TTM)-$0.83

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 96.85% of the $345.95M in total assets.

    Cash and Equivalents$320.32M
    Total Debt$868.50K
    Net Cash$319.45M
    Net Cash Per Share$4.31
    Working Capital$328.05M
    Shareholder Equity$335.06M
    Book Value Per Share$4.52
    Total Assets$345.95M
    Total Liabilities$10.89M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $339.90K of capital spending, operating cash flow left -$45.24M of free cash flow.

    Operating Cash Flow-$44.90M
    Capital Expenditures$339.90K
    Free Cash Flow-$45.24M
    FCF Per Share-$0.55
    Depreciation and Amortization$467.86K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)+72.49%
    Tangible Book Per Share Growth (2Y CAGR)+72.49%

    Revenue and profit by year

    Dividends and Yields

    IMMX does not pay a dividend. Its free cash flow yield is -8.48%.

    FCF Yield-8.48%
    Buyback Yield-37.28%
    Shareholder Yield-37.28%

    Peer Position

    Against 7 similar companies, IMMX has the 3rd highest ROIC.

    ROIC-14.91% vs -53.81% median
    Revenue Growth (Trailing 4 Quarters, YoY)-100.00% vs -68.20% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About IMMX

    What is IMMX's market cap?

    Immix Biopharma has a market cap of $657.09M. Its enterprise value, which adds debt and subtracts cash, is $337.64M.

    How many shares of IMMX are outstanding?

    Immix Biopharma has 74.09M shares outstanding. The count is up 132.06% from a year earlier.

    Does IMMX pay a dividend?

    No. Immix Biopharma does not pay a dividend.

    How much debt does IMMX have?

    Immix Biopharma has $868.50K of total debt and $320.32M of cash and equivalents, a net cash position of $319.45M.